A rare missense variant in the ATP2C2 gene is associated with language impairment and related measures by Martinelli, Angela et al.
This is a repository copy of A rare missense variant in the ATP2C2 gene is associated with
language impairment and related measures.




Martinelli, Angela, Rice, Mabel L, Talcott, Joel B et al. (12 more authors) (2021) A rare 
missense variant in the ATP2C2 gene is associated with language impairment and related 





This article is distributed under the terms of the Creative Commons Attribution (CC BY) licence. This licence 
allows you to distribute, remix, tweak, and build upon the work, even commercially, as long as you credit the 
authors for the original work. More information and the full terms of the licence here: 
https://creativecommons.org/licenses/ 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
Received: January 16, 2021. Revised: April 9, 2021. Accepted: April 12, 2021
© The Author(s) 2021. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/),
which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
1160
Human Molecular Genetics, 2021, Vol. 30, No. 12 1160–1171
doi: 10.1093/hmg/ddab111
Advance Access Publication Date: 16 April 2021
Association Studies Article
AS SOC I AT I ON STUD I E S ART I C L E
A rare missense variant in the ATP2C2
gene is associated with language
impairment and related measures
Angela Martinelli1, Mabel L. Rice2, Joel B. Talcott3, Rebeca Diaz1,
Shelley Smith4, Muhammad Hashim Raza2, Margaret J. Snowling5,
Charles Hulme6, John Stein7, Marianna E. Hayiou-Thomas8, Ziarih Hawi9,
Lindsey Kent1, Samantha J. Pitt1, Dianne F. Newbury10 and
Silvia Paracchini1,*
1School of Medicine, University of St Andrews, St Andrews, UK, 2Child Language Doctoral Program, University
of Kansas, Lawrence, KS, USA, 3Aston Brain Centre, School of Life and Health Sciences, Aston University,
Birmingham, UK, 4Department of Neurological Sciences, University of Nebraska Medical Center, Lincoln, NE,
USA, 5Department of Experimental Psychology and St John’s College, University of Oxford, Oxford, UK,
6Department of Education, University of Oxford, Oxford, UK, 7Department of Physiology, University of Oxford,
Oxford, UK, 8Department of Psychology, University of York, York, UK, 9Turner Institute for Brain and Mental
Health, School of Psychological Sciences, Monash University, Clayton, VIC, Australia and 10Department of
Biological and Medical Sciences, Oxford Brookes University, Oxford, UK
*To whom correspondence should be addressed at: School of Medicine, North Haugh, St Andrews KY16 9TF, UK. Tel: +44 (0)334 462542;
Email: sp58@st-andrews.ac.uk
Abstract
At least 5% of children present unexpected difficulties in expressing and understanding spoken language. This condition is
highly heritable and often co-occurs with other neurodevelopmental disorders such as dyslexia and ADHD. Through an
exome sequencing analysis, we identified a rare missense variant (chr16:84405221, GRCh38.p12) in the ATP2C2 gene. ATP2C2
was implicated in language disorders by linkage and association studies, and exactly the same variant was reported
previously in a different exome sequencing study for language impairment (LI). We followed up this finding by genotyping
the mutation in cohorts selected for LI and comorbid disorders. We found that the variant had a higher frequency in LI cases
(1.8%, N=360) compared with cohorts selected for dyslexia (0.8%, N=520) and ADHD (0.7%, N= 150), which presented
frequencies comparable to reference databases (0.9%, N= 24046 gnomAD controls). Additionally, we observed that carriers
of the rare variant identified from a general population cohort (N= 42, ALSPAC cohort) presented, as a group, lower scores on
a range of reading and language-related measures compared to controls (N=1825; minimum P=0.002 for non-word
reading). ATP2C2 encodes for an ATPase (SPCA2) that transports calcium and manganese ions into the Golgi lumen. Our
functional characterization suggested that the rare variant influences the ATPase activity of SPCA2. Thus, our results further




































































Human Molecular Genetics, 2021, Vol. 30, No. 12 1161
Introduction
Speech and language disorders represent one of the most
common childhood disabilities and account for a large pro-
portion (23%) of paediatric referrals and statements of special
educational need (School census, England, January 2019, https://
www.gov.uk/government/statistics/special-educational-nee
ds-in-england-january-2019).
Speech and language deficits are often the secondary
manifestations of a pre-existent neurological or medical
condition (e.g. Down syndrome, intellectual disability, autism
spectrum disorder, hearing loss, traumatic brain injury and
mental retardation). Severe and persistent language difficulties
can be observed also despite normal intelligence and access to
adequate educational opportunities. In this case, children were
diagnosed with specific language impairment (SLI) (1). Recently,
the use of this term has been replaced by the developmental
language disorder (DLD) definition (2,3), which captures a
wider group of children presenting co-occurring conditions
such as intellectual disability, ADHD and developmental
coordination disorder. Previous genetic research and the
samples described here refer to participants recruited under
the SLI criteria, and therefore, we will use the terms SLI and LI
hereafter.
SLI affects up to 8% of pre-school children (4,5) and has a
significant impact on social, academic and psychological out-
comes (6–10). SLI often co-occurs with other neurodevelopmen-
tal disorders such as dyslexia (11,12) and attention deficit/hyper-
activity disorder (ADHD) (13). The comorbidity observed between
these conditions suggests that SLI, dyslexia and ADHD may be
different manifestations of the same cognitive deficit or share
common genetic factors (14). This hypothesis is supported by
significant genetic overlap across studies as demonstrated by
a recent genome-wide association study (GWAS) for dyslexia
which showed significant shared contributions across disorders
(15).
A strong genetic component for DLD, of up to 70%, was first
proposed by twin and familial studies (16–20).
Initially, linkage studies conducted across multiplex fami-
lies led to the identification of 5 susceptibility loci on chromo-
somes 2q36 (SLI5, OMIM #615432) (21), 7q35-q36 (SLI4—OMIM
#612514) (22), 13q21 (SLI3—OMIM #607134) (23,24), 16q (SLI1—
OMIM #606711) and 19q (SLI2—OMIM #606712) (25–28). Finemap-
pingwithin these regions reported associations of common vari-
ants at theATP2C2,CMIP,CNTNAP2 geneswith quantitativemea-
sures of language abilities (22,29), including the phonological
memory non-word repetition task (NWR), which is considered
as a strong endophenotype for SLI (30).
GWAS for language skills have been conducted in clinical
and epidemiological samples but have been limited to a few
studies of relatively small sample sizes (31). In the first case, the
only locus reaching genome-wide significance in SLI individuals
was found in the NOP9 gene, when including parent-of-origin
effects (32,33). In the second case, the most significant result
was the association between the locus 3p12.3, near ROBO2, and
expressive vocabulary in the early phase of language acquisition
(34). A GWAS conducted in two population cohorts reported
an association close to statistical significance between ABCC13
gene and the NWR test (35). Other studies combined analyses for
language and reading abilities using both a case–control (36) and
quantitative design (37) reporting only marginally significant
associations.
Chromosomal rearrangements and copy number variants
(CNV) have also been implicated in the aetiology of LI. Children
with SLI show a higher frequency of sex chromosome aneuploi-
dies (38) and an increased CNV burden compared with popula-
tion controls (39,40). A balanced translocation interrupting the
gene SEMA6D (41) has been identified in a child with SLI. Rare
deletions have been reported in the ZNF277 (42) and TM4SF20
(SLI5) genes (21). Larger de novo deletions have been reported
across the ATP2C2 gene in a 10-year-old boy with receptive and
expressive language delay (43) and at chromosome 15q13.1–
13.3 in a child with LI (44). Single locus mutations have been
implicated in severe forms of language disorders (31,45). De novo
mutations in the FOXP2 gene cause childhood apraxia of speech
(CAS), a severe oral-motor delay accompanied by deficits in
expressive and receptive language (46).
Next-generation sequencing (NGS) technology is uncovering
the role of rare variants in complex traits. NGS in individuals
with CAS or SLI pinpointed to novel pathogenic variants in cod-
ing and non-coding regions (45,47,48). Whole exome sequencing
(WES) analysis in 43 unrelated probands affected by severe SLI
(49) reported several risk variants but suggested that a single
mutation might not be sufficient to lead to a disorder unless
in combination with other factors in line with previous studies
(50–52).
Here, we followed up a specific finding from ongoing
exome sequencing analyses on large pedigrees selected
for having multiple members affected by SLI. We iden-
tified, in one family, a rare non-synonymous variant in
the ATP2C2 gene (Chr16:84405221 GRCh38.p12, rs78887288,
NM_001286527:exon3:c.G304A:p.V102M), previously implicated
in SLI through association studies (29,43). Exactly the same
variant was also reported in the WES study by Chen and
collaborators (49) bolstering the idea that this rare variant has a
role in susceptibility to language disorders. Nonetheless, given
its rarity, larger screens and functional studies are required to
support this role.
We screened the chr16:84405221 variant in larger cohorts
of children with language difficulties. Due to the high rate of
comorbidity between SLI, dyslexia and ADHD, the screening
included cohorts selected for these conditions.
We found that this variant had a higher frequency in
the SLI and LI cases compared with the control group and
cohorts selected for dyslexia or ADHD. Additionally, this
variant was associated with low performance in a range of
reading and language measures. By means of a colorimetric
ATPase assay, we further investigated the effects of the
variant on the function of SPCA2, the calcium and manganese
transporter encoded by ATP2C2. The mutation displayed a
lower, albeit not significant, ATPase activity compared with
SPCA2 WT.
Results
Identification of the missense variant Chr16:84405221
WES analysis in six families selected for SLI led to the identi-
fication of a rare variant (Chr16:84405221) in the ATP2C2 gene
(Fig. 1). This variant was found in two children and their father,
all diagnosedwith SLI. The same variantwas previously reported
in an exome sequencing study performed on 43 unrelated
probands affected by severe LI (49). ATP2C2 was previously
associated with SLI (29). Sanger sequencing in the other family
members showed imperfect segregation as the variant was
not transmitted to the other two affected sons (Fig. 1). The
variant was inherited from the father who also scored below
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Figure 1. The rare ATP2C2 missense variant (Chr16:84405221). (A) Discovery pedigree. Father (1), mother (2), proband (3) and siblings (4–6). Subjects with SLI are shaded
black and unaffected are white. Individuals included in the WES screening are indicated by an asterisk. (B) Allele-specific PCR. The presence of the missense variant
was validated in follow up screening using PCR 3′-end mismatch primers. Depending on the allele present, the forward primer anneals perfectly to the template or
forms a mismatch. The reaction gives an amplicon only in the first case. (C) On top, a schematic of the ATP2C2 gene. Exons are represented by numbered boxes. The
rare variant is localized in the third exon (red arrow) and causes the substitution of the residue from valine to methionine. Exons and introns of ATP2C2 gene are not
to scale. At the bottom, predicted domains of the protein (http://www.rcsb.org/pdb/protein/O75185) (118). The variant changes the amino acid sequence which codes
for the cation transporting ATPase domain at the N-terminal of the protein.
Table 1. Predictions of the possible effects of the ATP2C2 missense
variant (chr16:84405221)
Computational tool Score (cut-off)a Prediction
SIFT 0.24 (0< s<0.05) Tolerated
Mutation assessor 1.535 (s>3.5) Low functional
impact
PROVEAN −0.399 (s≤ −2.5) Neutral
PolyPhen-2 0.002 (0.85< s< 1.0) Benign
MutPred 0.114 (s>0.50) Benign
INPS-MD −0.073 (s< −0.5) Weak destabilising
effect
MutationTaster 21 (s≥151) Conservative
aCut-off scores (s) for predicting functional effects.
measure. The variant leads to a missense substitution from
a valine to a methionine in exon three spanning the ATPase
domain. Bioinformatics tools for pathogenicity suggest the
change is likely to be benign (Table 1). The two algorithms that
predicted a functional effect, albeit subtle, on protein activity
and stability were the Mutation Assessor and the INPS-MD
tools.
Genotyping of Chr16:84405221 in the SLI, dyslexia and
ADHD cohorts
The variant was genotyped in independent cohorts with LI,
dyslexia or ADHD (Table 2). The frequency of the variant was
2.2% in the SLIC cohort selected for SLI and 1.8% across all
the unrelated LI cases (combined LI samples, N=360), including
the discovery family and previously published data (49). The
frequency was 0.8% in the combined dyslexia samples (N=520)
and 0.7% in the combined ADHD cases (N=151).
In theALSPAC super-controls (N=681), the variant occurred at
a frequency of 1%.The frequency in the global gnomADdatabase
is of 0.5% (N=59718) and of 0.9% in the European population
(N=24046).
Although the frequency was higher in the LI cases (1.5%)
than the controls (1%) derived from the ALSPAC cohort, the
difference was not statistically significant when examined with
a two-tailed Fisher’s exact test (P=0.152).
Mean score of language and reading-related
phenotypes
We evaluated the effects of the variant on a range of language-
related quantitative measures available for the ALSPAC cohort
(Supplementary Material, Table S4). The carriers (N=42) had
lower mean scores compared with the non-carriers (N=1825)
on all tested measures, reaching nominal statistical signif-
icance (t-test, two-tailed distribution) for six traits: READ
(P=0.016), SPELL (P=0.006), PHONEME (P=0.026), NW_READ
(P=0.002), VIQ (P=0.006) and PIQ (P=0.022) (Table 3). NW_READ
survived a conservative Bonferroni correction for multiple
comparison (10 tests, threshold for significance=0.005; see
also Supplementary Material, Table S5 for analysis through
the Wald test and Supplementary Material, Fig. S2 for box
plots). It is worth noting that the 10 tests are not completely
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Table 2. Frequency of the rare allele A (Chr16:84405221) across different cohorts
Cohort Cohort type N Allele A count Allele A frequency Reference
SLIC Clinical 161 casesa 7 2.2% (26)
York Longitudinal 23 LI casesb 0 0% (53)
18 dyslexia cases 3∗ 8.3%
72 TD 1 0.7%
Dyslexia Clinical 471 cases 5 0.5% (54)
ADHD Clinical 141 cases 2 0.7% (55)
ALSPAC Longitudinal
Epidemiological
170 LI casesc 5 1.5% (56,57)
31 dyslexia cases 0 0%
10 ADHD cases 0 0%
Combined cases
Combined SLI/LI samples 360 casesd 13 1.8%
Combined dyslexia samples 520 cases 8∗ 0.8%




681 controls 14 1% (56,57)
European population
(gnomAD v2.1.1)
24 046 controls 426∗∗ 0.9% (58)
gnomAD v2.1.1 59 718 controls 584∗∗∗ 0.5%
aIncluding the probands analyzed by Chen and colleagues through exome sequencing (Chen et al., 2017).
bIncludes N=11 individuals with comorbid SLI and dyslexia.
cIncludes N=9 individuals with comorbid LI and dyslexia.
dIncluding the six probands screened by whole exome sequencing.
∗includes N=1 homozygote; ∗∗includes N=2 homozygotes; ∗∗∗includes N=3 homozygotes.
Abbreviations: ADHD: attention deficit hyperactivity disorder.
Table 3. Mean score of different phenotypes across carriers and non-carriers (ALSPAC cohort)
Genotype (total N) Mean score (SD; N)
Reading measures Language measures IQ
READ SPELL PHONEME NW_READ WOLD NWR MEMSPAN CCC_average7 VIQ PIQ
GA or AA (42) 26.6 6.4 17.8 4.3 7.6 7.2 3.3 31.1 104.4 97.4
(9.8; 38) (4.3; 37) (9.5; 38) (2.4; 39) (1.8; 37) (2.5; 37) (0.8; 34) (1.2; 37) (13.6; 38) (16.2; 39)
GG (1825) 30.1 8.3 21.2 5.5 7.8 7.5 3.5 31.3 112.1 103.7
(8.7; 1707) (4.3; 1696) (9.4; 1710) (2.4; 1763) (1.9; 1711) (2.4; 1711) (0.8; 1622) (1.1, 1722) (16.6; 1703) (16.8, 1701)
P (t-test) 0.016 0.006 0.026 0.002 0.533 0.503 0.131 0.311 0.006 0.022
Comparisons were evaluated with a Student’s t-test; P< 0.05 are indicated in bold. The threshold for Bonferroni correction based on 10 tests is 0.005.
Sample size varies depending on the availability of missing phenotypes. Details about each test can be found in Supplementary Material, Table S4.
READ, single-word reading accuracy; SPELL, single word spelling accuracy; PHONEME, phoneme awareness; NW_READ, nonword reading; WOLD, Listening and
comprehension test; NWR,nonword repetition; MEMSPAN,workingmemory; CCC_average7, average of first seven scales from the Children’s Communication Checklist;
VIQ, verbal IQ.
ATPase assay
An effect of allele A on the ATPase activity of SPCA2 was tested
with a colorimetric assay to quantify the inorganic phosphate
released during the catalytic reaction (Fig. 2A). Microsomes
were isolated from HEK293 cells overexpressing the wildtype
or mutated SPCA2-HA tagged protein. The activity of the
overexpressed SPCA2 WT sample was higher compared with
the negative controls (empty vector and untransfected cells)
across all the conditions. SPCA2 p.V102M displayed on average
a lower ATPase activity compared with that of the WT protein
(Fig. 2A). WB confirmed the overexpression of SPCA2 for the WT
and mutated constructs, while no protein was detected for the
negative controls, suggesting a very minimal effect of baseline
endogenous protein (Fig. 2B).
Discussion
In this study, we investigated the effects of a rare ATP2C2 variant
on LI and related disorders. Overall, we found that this variant
had a higher frequency in LI samples (1.8%, N=360) compared
with controls (1%, N=681, ALSPAC) and subjects with dyslexia
(0.8%, N=520) or ADHD (0.7%, N=150). The frequency reached
2.2% in a clinical cohort ascertained for SLI (N=161; Table 2). In
a general population sample derived from the ALSPAC cohort,
carriers of the rare variants presented lower scores compared
with non-carries on a range of language-related measures, with
the stronger effect observed for the non-word reading measure
(P=0.002; Table 3).
Taken together, our results suggest that theATP2C2missense
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Figure 2. Effect of the mutation on ATPase activity. (A) Concentration of free inorganic phosphate (Pi) released during the ATPase catalytic reaction. The activity is
expressed relative to the empty vector, normalized to 100%. The results are shown as mean percentages ± SD of two independent experiments. The samples are:
untransfected HEK293 cells (UT), microsomes isolated from HEK293 cells transiently transfected to overexpress the recombinant SPCA2-HA tagged (SPCA2 WT) or
mutated protein (SPCA2 p.V102M) and microsomes isolated from HEK293 cells transiently transfected with the empty vector (E). (B) Western blot. Each lane was loaded
with 5 μg of microsomes. The membranes were probed with antibodies against SPCA2 (top, green) or GAPDH (36 kDa) (bottom, red). SPCA2 can be detected when
overexpressed, while no signal is observed in the untransfected cells and the control samples. The band corresponds to the predicted SPCA2-HA tagged molecular
weight (105.2 kDa).
language measures. The presence of the ATP2C2 variant in
controls shows that it is not sufficient on its own to cause a
disorder and its association with a range of measures suggests
a pleiotropic effect on cognitive traits. These observations are
in line with the emerging findings in the field of complex
traits genetics and, specifically, for neurodevelopmental and
psychiatric disorders. For example, under the double-hit model,
a risk factor might lead to a specific disorder or a range of
conditions depending on the interactions with other genetic
risk variants (51,52,60). Under this model, the rare ATP2C2
variant might increase the risk for LI or affect performance
on reading- and language-related measures when combined
with different susceptibility factors, as observed for other
rare variants implicated in LI. These include a microdeletion
in ZNF277 (42), a rare stop-gain variant in ERC1 (49) and
nonsynonymous mutations in NFXL1 (61), GRIN2B and SRPX2
(Chen et al., 2017). Increasing evidence shows that the penetrance
of rare risk factors is modulated by the cumulative effect
of common risk alleles, even in severe neurodevelopmental
disorders usually assumed to have a monogenic origin (62).
Different manifestations determined by the interplay between
common and rare variants have been reported for conditions
such as schizophrenia (63,64), ADHD (65), autism spectrum
disorder (66), intellectual disability (67) and outcomes such
as educational attainment (68). Rare risk factors causing
psychiatric disorders have also been reported to have an
effect on cognitive abilities in the general population (69,70).
This is in line with what we observe for the ATP2C2 variant
which showed associations with poor performance on cognitive
traits in the ALSPAC sample regardless of any disorder group
assignment (Table 3). The variant is associated to lower mean
scores on a range of cognitive measures, with the strongest
effect observed for reading abilities rather than language
skills. Our results support the emerging idea that genetic
risk factors have generalized effects across cognitive and
neurodevelopmental traits, rather than specific genotype–
phenotype relationship. The same concept is illustrated also for
common variants through polygenic risk scores (PRSs) analysis.
For example, PRS for schizophrenia showed associations
for a number of traits including poor cognitive outcomes
(71) but also enhanced creativity (72), language performance
(73) and hearing (74). Similarly, PRSs for general cognitive
abilities show effects on reading and language measures
(15,75–77).
The ATP2C2 gene encodes for an ATPase that transports Ca2+
and Mn2+ into the Golgi lumen (78). ATPases are emerging as a
new class of proteins involved in neurodevelopmental disorders
(79–82). Ca2+ is involved in the regulation of several neuronal
processes such as neuronal migration, axon guidance, synap-
tic plasticity, memory, neuronal excitability, neurosecretion and
aging (83–86). Excessive accumulation of Mn2+ inside the cells
is toxic, induces apoptosis and causes manganism, a neuro-
logical disorder characterized by tremors and spasm (87,88).
Additionally, dysregulation of these cations has been linked to
Alzheimer’s, Parkinson’s and Huntington’s disease (89,90). The
transport of Ca2+ and Mn2+ ions inside the Golgi is essential
for the activity of enzymes involved in mechanisms such as
neurotransmitter synthesis, membrane trafficking, metabolism,
protein modification, sorting and folding (86). Previous studies
have shown thatATP2C2 is expressed in postnatal rat hippocam-
pal neurons (91) and in adult human brain (78,91,92), suggesting
a possible role of ATP2C2 in maintaining ionic homeostasis in
neurons.
The missense variant described in the current study is local-
ized in the cation transporting N-terminal domain and causes
the amino acid substitution from valine to methionine (Fig. 1).
The latter residue is characterized by an unbranched side chain
that provides increased flexibility. In addition to this, methio-
nine has a sulphur group that can influence the binding pref-
erence for metal ions and be reversibly oxidized converting the
hydrophobic amino acid into a highly polar one (93,94). Bioin-
formatic predictions do not attribute substantial detrimental
effects to the substitution, and therefore, any potential effects
are expected to be subtle (Table 1). We tested experimentally
whether the rare allele A had an effect on the SPCA2 activity,
through an ATPase assay. This approach allowed us to measure
the hydrolysis of ATP in a quick and sensitive way. Indepen-
dently of the concentrations tested, the rare variant displayed
on average a lower ATPase activity compared with SPCA2 WT
(Fig. 2). Although not statistically significant, the data suggested
a possible impact of the variant on the velocity of the reaction
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mutated transporter tended to present a lower ATP hydrol-
ysis indicative of a lower turnover rate and consequently a
higher ion affinity. In line with the bioinformatics prediction,
the rare variant does not affect the functionality of the protein
but might alter its performance which in turn, in combina-
tion with other factors,might contribute to neurodevelopmental
phenotypes.
In summary, we identified a rare missense variant (chr16:
84405221, GRCh38.p12) in ATP2C2, a previously reported candi-
date gene for LI. We showed that the rare allele A increases the
risk for LI cohorts and is associated with more general cognitive
abilities in a population-based cohort. Preliminary functional
characterization of the rare allele suggested that the rare variant
influences the ATPase activity of SPCA2 supporting follow up
functional studies to fully understand the role of this vari-
ant and the ATP2C2 gene. WES studies for language disorders
have been limited to samples, which makes the result inter-
pretation particularly challenging. Our results demonstrate that
combined analyses across disorders and phenotypes provide a
valid route to validate WES findings. Taken together, our results
further support a role of ATP2C2 in LI and pinpoint to a specific




An exome sequencing analysis was conducted in six pedigrees
of SLI probands with multiple affected members per family,
selected from an ongoing longitudinal study in the Midwestern
USA (95,96). The full results of this screening will be reported
in a separate manuscript. SLI probands were identified based
on language performance 1 standard deviation (SD) or more
below the mean on an age appropriate omnibus language
test (95) and met the following entrance screening criteria:
(i) a standard score above 85 on an initial age appropriate
test of non-verbal IQ, (ii) normal hearing acuity, (iii) no
history of neurological disorders or diagnosis of autism and
(iv) intelligible speech sufficient for language transcription.
Except for normal hearing acuity, the entrance screening
criteria did not apply to siblings and parents of SLI probands,
as their intellectual status was an outcome of the study
(95).
Here, we report the analysis and follow up of a specific
variant of interest (Chr16: 84405221) in one family (Fig. 1).
A male SLI proband, his younger male sibling (Sib 1) and
their parents were selected for WES. All family members
including the other two siblings were genotyped for the
ATP2C2 variant. Longitudinal phenotype data on the proband
were assessed from age 6 to 19 years and the siblings were
assessed also at multiple time points. Both mother and
father were tested at a single time point. All siblings and
the father met the criteria above for a clinical diagnosis of
SLI. The sibling selected for WES was also delayed on the
Test of Early Grammatical Impairment until age 7 years,
6 months (97). The children were also delayed in receptive
vocabulary and oral reading across age, as well as in mean
length of utterance when young. The study was approved by
the institutional review boards at the University of Kansas
and at the University of Nebraska Medical Center. Appropriate
informed consent was obtained from the subjects and/or their
caregivers.
Validation, genotyping and bioinformatics prediction
for the variant
Sanger sequencing was used to validate the variant and test all
available family members in the discovery pedigree.
The variant was then screened in larger cohorts with a Taq-
Man™ SNP Genotyping Assay run on a ViiA7 instrument (Life
Technologies, Paisley, UK). The presence of the mutation was
validated using PCR 3′-endmismatch primers (Fig. 1B).All primer
sequences are reported in Supplementary Material, Table S1. For
protocol details, see Supplementary Material, Tables S2 and S3,
and Supplementary Material, Fig. S1. The functional impact of
the rare ATP2C2 variant was estimated using the default settings
of seven different in silico prediction algorithms (Table 1), SIFT
(98), Mutation Assessor (99), PROVEAN (100), PolyPhen-2 (101),
MutPred (102), INPS-MD (103) and MutationTaster (104).
Cohorts for follow-up analysis
The genotyping was conducted across different UK cohorts of
children with LI, dyslexia or ADHD used in previous genetic
studies (Table 2). We use the SLI term when participants were
recruited under SLI criteria and the term LI to refer to individuals
who did not receive a specific diagnosis but presented language
difficulties on psychometric tests. Assignment to a case group
was based either on existing clinical diagnoses (York and ADHD
cohorts) or derived from poor performance on different psycho-
metric tests as specified below. Exclusion criteria included non-
European ethnicity, English as a second language, signs of other
sensory or neurological conditions and missing information for
the selected phenotypes.
The SLI Consortium (SLIC) cohort consisted of 263 families
(263 probands, 258 siblings, 526 parents) (age range 5–19 years)
recruited across different UK clinics (29). Participants were
assigned to a case category when they scored ≥80 on per-
formance IQ (PIQ) and had impaired expressive or receptive
language skills (ELS or RLS score≥ 1.5 SD below the normative
mean of the general population) as assessed through the Clinical
Evaluation of Language Fundamentals test (CELF-R, revised
version) (105). If the same family comprised several cases, the
most severe sibling was included into the analysis. Severity was
determined by comparing the scores for ELS and RLS composite
measure. If the cases performed at the same level on these
measures, inclusion was determined by the most severe score
on the NWR task. Overall, 161 unrelated cases met these criteria.
A subset of this samplewas used for theWES analysis conducted
by Chen and colleagues where the rare variant was also reported
(49). The ethical approval was given by local ethics committees
of the hospitals involved in the consortium, and all subjects
provided informed consent.
The York cohort consisted of 115 families (115 probands, 27
siblings, 184 parents), collected for a longitudinal study designed
to investigate language and reading development (53). Families
were recruited via advertisements and assessed for either having
a family history of dyslexia or showing preschool language diffi-
culties. Participants that did not meet these criteria and did not
present other impairments were assigned to the typically devel-
oping (TD) group. At 8 years, the children were given a clinical
diagnosis for SLI (N=23, including 11 individuals with dyslexia)
and dyslexia (N=18). Ethical approval was obtained from the
Yorkshire & The Humber—Humber Bridge NHS Research Ethics
and the Ethics Committee at theUniversity of York—Department
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Participants were assigned to a category of dyslexia from
two other separate cohorts of families and individual cases.
The criteria for the dyslexia, which is based on different cut-
off points than the ones used for SLI, were PIQ≥85 and a score
of 1 SD below the population mean on the single-word reading
(READ) test measured through the British Ability Scales (BAS)
(106) or the Wide Range Achievement Test (WRAT-R, revised
version) (107). The first cohort comprised 290 families (689 sib-
lings, 580 parents) (age range 6–27 years) described before (108).
All the subjects were recruited by the Dyslexia Clinic at the
Royal Berkshire Hospital, Reading, UK. When multiple children
from the same family met the above criteria, we referred to
other psychometric measures and selected the individual with
the most severe phenotype on the following tasks: BAS single-
word spelling accuracy (SPELL) (106), phonological decoding abil-
ity (CCN) (109), phonemic awareness (SPOON) (110) and ortho-
graphic coding skill assessed through the irregular word (CCI)
(109) or forced word choice test (OLSON) (111). The Dyslexia
Cases cohort, N=592 singletons (age range 6–18 years), was col-
lected from either the Dyslexia Research Centre clinics in Oxford
and Reading or the Aston Dyslexia and Development Clinic in
Birmingham (54). In total, N=471 participants met the above
criteria for dyslexia. The study was approved by the Oxfordshire
Psychiatric Research Ethics Committee and the Aston University
Ethics Committee and informed consent was given by all the
participants and/or their caregivers.
The ADHD cohort included 159 trios (age range 5–16 years)
recruited from child psychiatry clinics in the UK and Ireland (55).
Participants were interviewed employing the Child and Adoles-
cent Psychiatric Assessment (112). All the probands fulfilled the
DSM-IV (American Psychiatric Society, 1994) diagnostic criteria
for ADHD. Ethical approvals were acquired from the Trinity
College Dublin in Ireland and the University of Birmingham in
UK. Informed consent was obtained from the parents of all the
participants.
In addition to the clinical cohorts, we analyzed a subset
of samples from the Avon Longitudinal Study of Parents and
Children (ALSPAC, see Supplementary Material) (56,57) for which
low-read-depth whole-genome sequence (WGS) data were gen-
erated as part of theUK10Kproject. Sequence datawere provided
by ALSPAC in the form of variant call files generated on the
Illumina Hi-seq platform using paired-end 100 bp reads and
a standard GATK workflow. Full details of sequence protocols
have been reported before (113). For this manuscript, UK10K
participants were excluded from the analysis if they reported
a non-white European ethnicity, presented with overt hearing
difficulties or were affected by neurological conditions, which
may explain their language difficulties, such as autism,Asperger
syndrome or pervasive developmental disorder. Individuals with
missing information for the phenotypes of interest were also
excluded.
The criteria for an assignment to a LI category were a PIQ≥80
at age of 8.5 and a score either 1 SD below the population
mean on the Wechsler Objective Language Dimensions (WOLD)
comprehension test (114) at 8 years or 1 SD below the popula-
tion mean on both tests of syntax, and intelligibility and ver-
bal fluency, as assessed through the Children’s Communication
Checklist (CCC) (115) at 7.5 years. Assignment to the dyslexia
category was given based on a diagnosis reported by the mother
through a questionnaire and a PIQ score higher or equal to 85
at the age of 8.5. Assignment to the ADHD category was given if
the subject met the DAWBA DSM-IV diagnostic criteria and had
a PIQ>80 at the age of 8.5. Please note that the ALSPAC study
website contains details of all the data that is available through a
fully searchable data dictionary and variable search tool (https://
www.bristol.ac.uk/alspac/researchers/our-data/).
Participants were assigned to a ‘super-control’ group (N=681)
when they performed above the mean on tests of receptive
(WOLD comprehension) and expressive (CCC syntax and intel-
ligibility and fluency scores) language and had both verbal and
non-verbal IQ≥80. From the controls, we also excluded any
child who self-reported a need for special educational support
or speech and language therapy and children who self-reported
a diagnosis of neurodevelopmental disorder (ADHD, conduct
disorder, anxiety disorder, depressive disorder, dyslexia, dys-
praxia, dyscalculia, learning difficulties, speech and language
difficulties or developmental delay).
Overall, in the ALSPAC sample, we identified: N=170 LI cases,
N=31 dyslexia cases, N=10 ADHD cases and N=681 controls.
Nine individuals in the LI group presented comorbidity with
dyslexia.
Ethical approval for the study was obtained from the ALSPAC
Law and Ethics Committee and the Local Research Ethics Com-
mittees. Consent for biological samples has been collected in
accordance with the Human Tissue Act (2004). Informed consent
was signed by the parents after having received a complete
description of the study at the time of enrolment into theALSPAC
project, with the option for them or their children to withdraw
at any time.
The gnomAD v2.1.1 database (https://gnomad.broadinstitu
te.org/) was used as a reference European population (58). Of
note, this source includes the UK10K samples.
Quantitative analysis
While, in most cohorts, the number of carriers of the rare
variant was too small to conduct any meaningful quantitative
analysis, the ALSPAC dataset was suitable for this option.
All the individuals with available genotype (N=1867) were
included into the analysis. Carriers (N=42) and non-carriers
(N=1825) were compared for the mean score calculated for
reading and language-related measures including: single-
word reading accuracy (READ, target age: 7.5 year), single-
word spelling accuracy (SPELL, 7.5 year), phoneme awareness
(PHONEME, 7.5 year), working memory (MEMSPAN, 10.5 year),
listening and comprehension test (WOLD, 8.5 year), phonological
short-term memory test (NWR, 8.5 year), single-non-word
reading accuracy (NW-READ, 9.5 year), average of the first
seven scales from the Children’s Communication Checklist
(CCC-average7, 7.5 year) and PIQ (8.5 year) (See Supplementary
Material, Table S4 for more details). Statistical significance was
calculated with the Student’s t-test (equal variances, two-tailed
distribution).
ATPase assay
The humanATP2C2 coding sequencewas cloned into the expres-
sion vector pcDNA™5/TO [Invitrogen, kind gift from Professor
Galione (116)]. ATP2C2 cDNA was obtained from SK-BR-3 cells
maintained under standard conditions and amplified by high
fidelity PCR. The primers were designed to include a HindIII site
prior the Kozak consensus sequence and a NotI site immediately
before the stop codon (See Supplementary Material, Table S1
for the primer sequences). The ATP2C2 open reading frame was
placed under the control of a constitutive CMV promoter and in
frame with a downstream HA epitope tag. The SPCA2-HA tagged
plasmid was modified to introduce the missense variant (allele
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the GeneArt™ Site-Directed Mutagenesis kit (Thermo Fisher)
according to the manufacturer’s instructions. The sequences
were verified by Sanger sequencing (See Supplementary Mate-
rial, Table S1 for primer sequences).
Microsomes were prepared as described by Vandecaetsbeek
(117) with minor modifications (See Supplementary Material for
details). HEK293 cells were transfected with the ATP2C2 express-
ing constructs. The empty vector and untransfected cells were
used as controls.
ATPase activity was evaluated using the PiColorLock™ Gold
kit (Expedeon, Abcam) according to the manufacturer’s specifi-
cations. The assay was conducted in a 96-well plate and each
sample run in duplicates. The amount of free inorganic phos-
phate (Pi) released from each reaction was calculated by plot-
ting the absorbance against a series of Pi standards of known
concentration.
The data generated were presented as mean percentages ±
SD of two independent experiments. The activity of each sample
was expressed relative to that detected in the empty vector,
normalized to 100%. Pair-wise comparison between sampleswas
performed by the Welch’s t-test (unequal variances, two-tailed
distribution).
For western blot analysis, 5 μg of microsomes were mixed
with Laemmli buffer and incubated at room temperature for
30 min. Samples (5 μg per well) were separated on a precast
4–12% NuPAGE™ polyacrylamide gradient gel (Invitrogen). The
anti-SPCA2 (Abcam) and anti-GAPDH (Abcam) antibodies were
diluted 1:4000 and 1:5000 in 0.1% TBS-Tween™20 (Fisher BioRe-
agents™), respectively.
Supplementary Material
Supplementary material is available at HMG online.
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